Based in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.

Dan Koeppen is a corporate and securities partner in the firm's San Diego office. Dan specializes in corporate governance, mergers and acquisitions, public offerings, and venture capital financings. He has extensive experience representing public and private life science and technology companies in a wide range of sectors, including biotechnology, consumer products, data security, medical device, pharmaceutical, semiconductor, software, and social media, through all stages of their growth from start-up to mature public companies. In addition, Dan represents leading investment banks in their underwriting transactions, and regularly advises numerous venture capital firms and corporate strategic investors in connection with their investments in emerging growth companies.

Scott focuses on complex commercial and technology transactions and frequently advises companies with new and emerging technologies.

Nellie Brutocao is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. Her practice focuses on the life sciences industry, representing public and private companies in intellectual property and commercial transactions, including strategic alliances, research and development collaborations, technology licenses and acquisitions, supply, distribution and manufacturing agreements, sponsored research agreements, clinical trials arrangements, material transfer agreements, and co-promotion arrangements. She has also represented life sciences companies in complex commercial and patent disputes, including Hatch-Waxman litigation.

Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.

Dr. Alicia Umpierre is an associate at Wilson Sonsini, where she provides strategic IP counseling to clients in a variety of technologies, including biologics, personalized medicine, diagnostics, devices, and gene therapy. Her expertise includes global patent portfolio development and management, freedom-to-operate analysis, and patent diligence.

Dr. Laurie McNamara is a partner in the San Diego and San Francisco offices of Wilson Sonsini Goodrich & Rosati, where she focuses her practice on matters related to intellectual property and patent prosecution strategy for early-stage through clinical-stage therapeutics companies. She counsels clients on matters related to global patent portfolio development and strategy, non-infringement, patentability, and freedom-to-operate studies. She advises company clients in connection with major financial transactions such as collaboration agreements, venture financings, merger & acquisitions, and public offerings. In addition to company-side representation, Laurie works with top venture capital firms related to IP diligence of target companies for financings. Laurie has represented venBio, OrbiMed, Logos Capital, Venrock, Foresight Capital, Novo Holdings, Vida Ventures, Avalon BioVentures, Two Bear Capital, and Samsara BioCapital in connection with financings of target companies developing biologics therapeutic programs.

Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.